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Vaccinia virus encodes two regulators of the cellular antiviral response. The E3L gene is thought to act primarily by
sequestering double-stranded RNA, whereas the K3L gene is thought to act as a competitive inhibitor of the double-stranded
RNA-dependent protein kinase, PKR. The broad host range associated with vaccinia virus replication appears to be related
to the presence of these genes. The E3L gene is required for replication in HeLa cells, but is not required for replication in
BHK cells. On the contrary, the K3L gene is required for replication in BHK cells, but is dispensable for replication in HeLa
cells. Our results suggest that these cell lines varied in the expression of endogenous activatable PKR and that replication
of vaccinia virus in different cell lines led to altered levels of double-stranded RNA synthesis from the virus. Vaccinia virus
was able to overcome these cellular variations by regulating PKR activity through the synthesis of either E3L or K3L. The
results suggest that vaccinia virus has evolved a broad host range by maintaining both the E3L and the K3L genes. © 2002INTRODUCTION
Vaccinia virus (VV), a member of the Orthopox group,
has previously been characterized as a virus with a
broad host range and significant resistance to the anti-
viral effects of interferon (IFN) (Beattie et al., 1995; Davies
et al., 1993). The antiviral state present in interferon-
treated cells involves the induction of at least two inter-
feron-regulated pathways (Samuel, 1991). The double-
stranded RNA (dsRNA)-dependent protein kinase, PKR,
pathway involves the up-regulation of this enzyme in an
inactive form and activation requires binding to dsRNA or
other polyanions (Meurs et al., 1990; Gunnery and
Mathews, 1998). PKR bound to dsRNA undergoes an
autophosphorylation event and subsequently phosphor-
ylates various substrates including the  subunit of pro-
tein synthesis initiation factor eIF2, NF-90, and HIV tat
protein (Brand et al., 1997; Langland et al., 1999). The
phosphorylation of eIF2 leads to the interference of the
eIF2B-mediated exchange of GTP for GDP necessary for
the catalytic function of eIF2. This ultimately leads to the
inhibition of protein synthesis at the level of initiation.
Similar to the PKR pathway, the 2-5 oligoadenylate
synthetase (OAS) pathway involves the interferon-induc-
tion of an inactive form of the enzyme and activation
requires interaction with dsRNA (Kerr and Brown, 1978;
Carroll et al., 1997). Activated OAS synthesizes 2-5-
linked oligoadenylates, which activate RNase L. Acti-133vated RNase L cleaves mRNA and rRNA leading to the
inhibition of protein synthesis at the level of RNA stability.
Both PKR and OAS are present in most cell lines at a
basal level even in the absence of interferon treatment,
but activation requires the presence of dsRNA, or possi-
bly endogenous cellular protein activators such as PACT/
RAX (Patel et al., 2000; Ito et al., 1999).
Vaccinia virus, similar to many other viruses, has
evolved mechanisms to evade the antiviral activities as-
sociated with interferon. The VV E3L gene encodes the
dsRNA-binding proteins p20 and p25. These proteins
contain a highly conserved dsRNA-binding motif found in
many dsRNA-binding proteins, including PKR. The E3L
gene products inhibit activation of both PKR and OAS by
binding to and sequestering potential dsRNA activator
molecules. Various assays have demonstrated that
dsRNA binding is necessary for p20/p25 inhibition of
PKR activity and that excess dsRNA can overcome the
inhibitory effects of p20/p25 (Chang and Jacobs, 1993;
Shors et al., 1997). Recently, though less well character-
ized, the E3L gene products have been suggested to
inhibit PKR by direct interaction with PKR leading to
heterodimer formation (Romano et al., 1998).
The VV K3L gene has limited homology to the amino-
terminal region of eIF2. The K3L gene product inhibits
autophosphorylation of both PKR and eIF2 substrate
phosphorylation (Carroll et al., 1993). Both K3L and eIF2
bind to PKR at a similar or overlapping region in the
catalytic domain of the enzyme. It has been suggestedElsevier Science (USA)
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ing the inhibition of protein synthesis (Davies et al., 1992;
Carroll et al., 1993).
Both the E3L and the K3L gene products likely con-
tribute to the interferon-resistant phenotype associated
with VV. VV deleted of the E3L gene (VVE3L) has a
severely limited host range and is interferon-sensitive in
permissive cell lines (Beattie et al., 1995, 1996). VV de-
leted of K3L (VVK3L) has a more subtle phenotype. This
virus has a much broader host range and has only been
found to be interferon-sensitive in mouse L-929 cells
(Beattie et al., 1995). In a heterologous system, the E3L
gene products were able to rescue vesicular stomatitis
virus (VSV) from the antiviral effects of interferon, but
were unable to rescue the interferon sensitivity of en-
cephalomyocarditis virus (EMCV) (Shors et al., 1998). In
this same system, the K3L gene product was unable to
rescue VSV, but could rescue EMCV. These results sug-
gest that the necessity for either the E3L or the K3L gene
products for virus replication may be virus specific and
dependent on the cell type.
The work presented in this study further characterizes
dependence of VV on both E3L and K3L. WtVV express-
ing both E3L and K3L was able to replicate in both HeLa
cells and BHK cells in the absence of interferon. WtVV
was resistant to the effects of interferon in HeLa cells,
but was interferon sensitive in BHK cells. VVE3L had a
limited host range where, even in the absence of inter-
feron treatment, this virus was unable to replicate in
HeLa cells, but could replicate in the BHK cell line. An
opposite dependence of the virus for K3L expression
was observed where VVK3L was unable to replicate in
BHK cells, but had a wild-type phenotype in HeLa cells.
RESULTS
Host range of VV mutants
WtVV has previously been shown to have a broad host
range (Shors et al., 1997; Beattie et al., 1995). To deter-
mine the role of the interferon-resistance genes, E3L and
K3L, related to host range, viral constructs were obtained
which were deleted of these respective genes (Beattie et
al., 1995). As shown in Fig. 1, WtVV replicated well in both
HeLa cells and BHK cells over a single cycle of replica-
tion with over a three-log increase in viral titer. WtVV was
completely interferon-resistant in HeLa cells but, surpris-
ingly, was very interferon-sensitive in BHK cells where
replication was reduced by approximately two-logs.
VVE3L had a much more limited host range where no
replication of the virus was observed in HeLa cells, but
the virus replicated to wild-type levels in BHK cells. This
virus, similar to wtVV, was interferon-sensitive in BHK
cells. An opposite host range phenotype was observed
for VVK3L. This virus replicated to nearly wild-type
levels in HeLa cells and was interferon-resistant, but in
BHK cells, no replication was detected.
To determine whether an inhibition in protein synthe-
sis was responsible for altering the host range of the
viruses, proteins being synthesized at 6 h postinfection
(h.p.i.) were radiolabeled with [35S]methionine. With wtVV,
a switch from cellular protein synthesis to a preference
FIG. 1. Dependence of VV host range on the expression of E3L or K3L. The ability of VV to replicate in different cell lines was determined by a
single-cycle growth assay. Mock or interferon-treated HeLa or BHK cells were infected with wtVV, VVE3L, or VVK3L. Infected cells were harvested
at 0 and 30 h.p.i. and the amount of virus present in the lysate determined by a standard plaque assay using permissive RK13 cells.
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to viral protein synthesis was observed in both HeLa and
BHK cells (Figs. 2A and 2B, lanes A and C). Viral trans-
lation was still observed in HeLa cells pretreated with
interferon (Fig. 2A, lane D), but a complete block in viral
protein synthesis and a decrease in host protein synthe-
sis was observed in interferon-treated BHK cells (Fig. 2B,
lane D). These results agree with the lack of wtVV rep-
lication observed in interferon-treated BHK cells.
VVE3L demonstrated a complete shutoff of both viral
and host protein synthesis in mock-treated and inter-
feron-treated HeLa cells (Fig. 2A, lanes E and F). How-
ever, in replication-permissive BHK cells, levels of pro-
tein synthesis were indistinguishable from that of wtVV
(Fig. 2B, lane E). Again, upon interferon treatment of BHK
cells, VVE3L translation was completely blocked and
host protein synthesis was also significantly decreased
(Fig. 2B, lane F). As expected, VVK3L demonstrated
viral protein synthesis in HeLa cells similar to that of
wtVV (Fig. 2A, lanes G and H). However, in BHK cells, the
presence of viral translation products was significantly
reduced (Fig. 2B, compare lanes C and G). Interferon
treatment of BHK cells infected by VVK3L completely
blocked all viral protein synthesis, but only slightly de-
creased host protein synthesis (Fig. 2B, lane H).
The interferon pathway(s) involved in determining
host range
Since a reduction in viral protein synthesis appeared
to correlate with the limited host range observed with the
VV mutants, activity associated with the two well-char-
acterized interferon response pathways was assayed.
Activation of the OAS pathway has previously been char-
acterized by the degradation of the 28S- and 18S-ribo-
somal RNAs (Floyd-Smith et al., 1981). RNA extracts were
prepared from HeLa and BHK cells infected by the vari-
ous viral constructs. In HeLa cells, significant rRNA deg-
radation was observed only in cells infected by VVE3L
(Fig. 3A, lane C). This degradation was increased when
cells were pretreated with interferon (Fig. 3A, lane G). All
other viral infections did not show any significant rRNA
degradation (Fig. 3A, lanes B, D, F, and H). In viral-
infected BHK cells, rRNA degradation was not observed
in any of the samples, including VVE3L and VVK3L
lysates, either in the presence or in the absence of
interferon (Fig. 3B, lanes A–H). These results suggest
that the OAS pathway may be involved in the inhibition of
VVE3L replication in HeLa cells and that this pathway is
not involved in the inhibition of VV replication in BHK
cells.
To determine whether the PKR pathway may be in-
volved in regulating viral replication in these cell lines,
various assays were performed. In Fig. 4, extracts from
viral-infected HeLa and BHK cells were assayed for the
presence of phosphorylated eIF-2 by Western blot. In
HeLa cells, infection by VVE3L showed high levels of
eIF2 phosphorylation either in the presence or in the
absence of interferon (Fig. 4, lanes E and F). The per-
centage of eIF2 phosphorylated is calculated relative to
the maximal amount of phosphorylation that could be
detected in that cell line. Therefore, 85% of the eIF2
phosphorylated during the infection of interferon-treated
HeLa cells by VVE3L (Fig. 4, lane F) could be phosphor-
ylated during the infection by this virus in non-interferon-
treated HeLa cells (Fig. 4, lane E). In BHK cells, eIF2
phosphorylation could be detected in all VV-infected
FIG. 3. Activation of the 25 oligoadenylate synthetase pathway in
HeLa cells. To monitor activation of the OAS pathway, total RNA was
isolated from virally infected HeLa and BHK cells at 12 h.p.i. Isolated
RNA was separated on an agarose-formaldehyde gel and visualized by
staining with ethidium bromide. The position of the 28S- and 18S-
ribosomal RNAs is indicated. Mock (lanes A–D) or interferon-pretreated
(lanes F–H) cells were either mock-infected (lanes A and E) or infected
with wtVV (lanes B and F), VVE3L (lanes C and G), or VVK3L (lanes
D and H).
FIG. 2. Inhibition of protein synthesis correlated with the viral host
range. To determine level of protein synthesis during viral infection,
infected HeLa and BHK cells were radiolabeled at 6 h.p.i. with [35S]me-
thionine. Detergent lysates were then prepared and the radiolabeled
proteins separated by SDS–PAGE and visualized by autoradiography.
Cells were either mock-infected (lanes A and B), or infected with wtVV
(lanes C and D), VVE3L (lanes E and F), or VVK3L (lanes G and H).
Prior to infection, cells were either mock-treated (lanes A, C, E, and G)
or treated with interferon (lanes B, D, F, and H).
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cells which had been pretreated with interferon (Fig. 4,
lanes D, F, and H). In the absence of interferon pretreat-
ment of BHK cells, eIF2 phosphorylation was only ob-
served in cells infected by VVK3L (Fig. 4, lane G). These
results clearly suggest the need for K3L for replication of
VV in BHK cells. Interestingly, infection with VVK3L in
BHK cells treated with IFN had similar levels of eIF2
phosphorylation as infection with VVE3L, but the level
of host translational shutoff was minor in the cells in-
fected with VVK3L and nearly complete in cells infected
with VVE3L (Fig. 2, lanes F and H).
To further confirm the activation of PKR leading to
eIF2 phosphorylation, Western blot assays were done
to detect the activated form of PKR. Two different anti-
serums were used in this assay, anti-PKR 71/10 and
anti-PKR M-550, neither of which were sensitive enough
to detect PKR in the absence of interferon treatment (Fig.
5, lane A). Upon activation of PKR, previous investigators
have observed an electrophoretic mobility shift of the
enzyme relative to the nonactivated state (Langland and
Jacobs, 1992). As shown in Fig. 5, when HeLa cell ex-
tracts are separated by SDS–PAGE and the PKR protein
detected by Western blot using anti-PKR 71/10 serum, a
shift in PKR electrophoretic mobility was observed in
extracts from VVE3L-infected cells compared to mock-
infected or cells infected by the other VV constructs (Fig.
5, compare lane F to lanes B, D, and H). When a similar
assay is performed using a different PKR antiserum (anti-
PKR M-550), the shifted or activated form of the protein
could not be detected (Fig. 5, lane F). Since the anti-PKR
71/10 serum was able to detect the activated/shifted form
of PKR, the loss of signal using the anti-PKR M-550 was
likely due to the loss of an epitope and not protein
degradation.
Unfortunately, the anti-PKR 71/10 serum will not detect
PKR from BHK cells even in the presence of interferon
(data not shown). When a similar Western blot was per-
formed using extracts from VV-infected BHK cells and
probing for PKR using the anti-PKR M-550 serum, a
reduction in the PKR signal was observed. Infection of
interferon-treated BHK cells with WtVV reduced the PKR
signal in extracts from virus infected cells (reduced 44%)
(Fig. 5, compare lanes B and D). Similar results were also
observed upon infection by VVE3L (nondetectable PKR
level) (Fig. 5, lane F) and VVK3L (PKR reduced by 85%)
(Fig. 5, lane H). Since with HeLa cells a loss of signal
corresponded to activation of PKR, it was likely that a
similar activation event occurred in interferon-treated
infected BHK cells.
To confirm that the loss of the PKR signal in the BHK
Western blot in Fig. 5 was due to the loss of an epitope
upon phosphorylation/activation of PKR and not degra-
dation of PKR, extracts from VVE3L-infected BHK cells
were phosphatase treated. Phosphatase-treated sam-
ples were then assayed by Western blot using anti-PKR
M-550 serum. Again, as shown in Fig. 5, PKR could not
be detected in interferon-treated BHK cells infected with
VVE3L (Fig. 6, lane E). When the VVE3L-infected cell
FIG. 5. Activation of PKR in HeLa and BHK Cells. HeLa or BHK cells
were untreated (lanes A, C, E, and G) or pretreated with IFN (lanes B,
D, F, and H). The monolayers were then mock-infected (lanes A and B)
or infected with wtVV (lanes C and D), VVE3L (lanes E and F), or
VVK3L (lanes G and H). At 6 h.p.i., RIPA cell lysates were prepared
and assayed by Western blot using two different antisera to PKR. Bound
antibodies were detected by chemiluminescence and visualized by
autoradiography. The upper two gels represent HeLa cell extracts
probed with monoclonal anti-PKR 71/10 from Ribogene (upper gel) or
anti-PKR M-550 from Santa Cruz Biochemicals (middle gel). The lower
gel represents BHK extracts probed with anti-PKR 71/10. The position of
nonphosphorylated PKR (PKR) and phosphorylated PKR (PKR-P) is
shown. The relative level of nonphosphorylated PKR (as compared to
mock-treated cells) in BHK cells is indicated.
FIG. 4. eIF2 phosphorylation in HeLa and BHK cells. HeLa or BHK
cells were untreated (lanes A, C, E, and G) or pretreated with IFN (lanes
B, D, F, and H). The monolayers were then mock-infected (lanes A and
B) or infected with wtVV (lanes C and D), VVE3L (lanes E and F), or
VVK3L (lanes G and H). At 6 h.p.i., RIPA cell lysates were prepared
and assayed by Western blot using antiphosphorylated eIF2 anti-
serum. Bound antibodies were detected by chemiluminescence and
visualized by autoradiography. The position of eIF2 is shown and the
relative level of eIF2 phosphorylation indicated.
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extract was treated with phosphatase, PKR detection
was restored with an electrophoretic mobility corre-
sponding to that of the nonactivated form of PKR (Fig. 6,
lane F). The amount of PKR present in this sample was
similar to that observed in mock-infected cells (Fig. 6,
compare lane F to lanes C and D). These results suggest
that PKR was phosphorylated/activated upon infection of
interferon-treated BHK cells by all the VV constructs
shown in Fig. 5.
Mechanism of PKR activation in BHK cells
The presence of excess free dsRNA is one mecha-
nism by which PKR may become activated in interferon-
treated BHK cells. Free dsRNA could be present in these
infected cells if lower levels of E3L were synthesized by
VV. To test this hypothesis, extracts from both interferon-
treated HeLa and BHK cells were assayed for levels of
E3L protein at various times postinfection by wtVV. In
both cell lines, similar rates of synthesis and levels of
accumulation of E3L protein were observed (data not
shown). Pretreatment of cells with interferon did not alter
these levels (data not shown). These results suggest that
the levels and timing of E3L protein synthesis was not
cell-line specific.
Free dsRNA may also be observed in BHK cells if VV
produced higher levels of dsRNA when replicating in
BHK cells as compared to replication in HeLa cells. If this
occurred, at some point, the concentration of dsRNA may
be high enough to overcome the sequestering effect of
E3L protein, thereby allowing activation of PKR. The
relative amount of RNase-resistant RNA, equivalent to
dsRNA, was determined from BHK and HeLa cells in-
fected by wtVV. The purified total RNA was either rehy-
bridized to assay the total amount of dsRNA possible
(Fig. 7B) or tested directly to assay the amount of dsRNA
present in the extract (Fig. 7A). With HeLa cells, only a
minor detectable increase in the amount of dsRNA was
observed between 0 and 12 h.p.i. (Figs. 7A and 7B). With
BHK cells, 3–10-fold increase in the amount of dsRNA
was observed between 6 and 12 h.p.i., relative to 0 h.p.i.
(Figs. 7A and 7B). Both HeLa and BHK cells began at
0 h.p.i. with approximately the same percentage of
dsRNA; therefore, the increase in dsRNA levels in BHK
cells was likely synthesized during the replication of VV
in this cell line.
These results suggest that during the replication of VV
in BHK cells, more dsRNA was produced than replication
in HeLa cells. If this were the case, the amount of free
E3L protein unbound to dsRNA would be expectedly
higher in HeLa cells than BHK cells. To assay for this, the
E3L protein present in detergent lysates from wtVV-in-
fected HeLa and BHK cells was affinity purified using
dsRNA-agarose. The E3L protein binds to dsRNA with a
very high affinity, and therefore, any E3L protein bound to
dsRNA present in the cell extract would be unable to
bind to the dsRNA agarose resin. The amount of free E3L
protein present in the extract was then ascertained by
comparing the total amount of E3L protein to the amount
of E3L protein which could be affinity purified on the
dsRNA-agarose resin. As shown in Fig. 8, approximately
5–10% of the E3L protein in BHK cells existed in a free
state (i.e., unbound to dsRNA) as compared to approxi-
mately 40–60% in HeLa cells. These results support the
idea that VV replication in BHK cells led to higher levels
FIG. 7. Vaccinia virus replication in BHK cells synthesized higher
levels of dsRNA than replication in HeLa cells. HeLa or BHK cells were
untreated or pretreated with IFN. The monolayers were then infected
with wtVV. Two hours prior to harvest, cells were radiolabeled with
[3H]uridine. At the indicated times, cells were harvested and total RNA
isolated and quantified. In A, the total RNA was treated with RNase A
and RNase T1 and the percentage of RNase-resistant RNA plotted. In
B, the total RNA was denatured and reannealed prior to RNase treat-
ment and quantification of RNase-resistant RNA.
FIG. 6. PKR Antiserum M-550 did not recognize phosphorylated/
activated PKR. BHK cells were untreated (lanes A and B) or pretreated
with IFN (lanes C–F). The monolayers were then mock-infected (lanes
A–D) or infected with VVE3L (lanes E and F). At 6 h.p.i., RIPA cell
lysates were prepared and left untreated (lanes A, C, and E) or treated
with CIAP (lanes B, D, and F). PKR was detected by Western blot using
anti-PKR M-550 antiserum (Santa Cruz Biochemicals). Bound antibod-
ies were detected by chemiluminescence and visualized by autora-
diography. The position of nonphosphorylated PKR (PKR) is shown.
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of dsRNA synthesis, and consequently, lower levels of
free E3L protein as compared to HeLa cells.
DISCUSSION
The vaccinia E3L and K3L gene products have previ-
ously been shown to inhibit the interferon antiviral re-
sponse, thereby allowing the virus to circumvent the
shutoff of protein synthesis in the infected cell (Chang
and Jacobs, 1993; Shors et al., 1997; Beattie et al., 1995).
One mechanism by which the E3L gene products are
known to function is by sequestering dsRNA (Chang and
Jacobs, 1993). As demonstrated here, the E3L gene prod-
ucts were both necessary and sufficient to inhibit the
antiviral response and permit replication of the virus in
HeLa cells. In HeLa cells, the E3L products likely bind to
and “mask” virtually all the dsRNA synthesized by the
virus at late times postinfection. This sequestering pre-
vents recognition of the dsRNA by either PKR or OAS,
thereby inhibiting the activation of these enzymes. Dele-
tion of the K3L gene appeared to have little, if any, effect
on the replication of VV in HeLa cells. Furthermore, the
presence of the K3L gene was unable to rescue replica-
tion of virus deleted of the E3L gene. We have previously
observed that HeLa cells endogenously synthesize rel-
atively large amounts of PKR even in the absence of
interferon treatment. Since the K3L gene product is
thought to function as a competitive inhibitor for both
eIF2 phosphorylation and possibly PKR autophosphor-
ylation (Davies et al., 1992; Carroll et al., 1993), excess
molar amounts of PKR relative to K3L would be expected
to overcome to the inhibitory effects of K3L. The data
presented support this concept that the E3L gene prod-
ucts were able to sequester any dsRNA synthesized by
the virus, preventing PKR binding to the dsRNA. How-
ever, in the absence of the E3L gene, PKR could bind to
the dsRNA, but due to the excess levels of PKR, the K3L
gene product was unable to fully inhibit PKR activation
and subsequently led to eIF2 phosphorylation (Fig. 9).
In the BHK cell line an opposite dependence of K3L vs
E3L on virus replication was observed. Here VV deleted
of E3L replicated to levels indistinguishable from wtVV,
but virus deleted of the K3L gene was debilitated. Fur-
thermore, the presence of E3L, K3L, or both were unable
to rescue replication of the virus from the antiviral effects
of interferon. This cell line has been demonstrated to
have phenotypic differences from HeLa cells in two im-
portant ways. First, while immunoreactive PKR could be
detected in BHK cells (Fig. 5), no activation of PKR could
be detected under in vitro phosphorylation conditions.
This is due to the presence of a cellular PKR inhibitor
(Kibler et al., 1997; data not shown). Second, VV replica-
tion in BHK cells appeared to lead to higher levels of
dsRNA synthesis than viral replication in HeLa cells. It is
our hypothesis that the replication of VV in BHK cells led
to high enough concentrations of dsRNA such that the
E3L gene products could no longer fully sequester all the
dsRNA present. PKR was then able to bind the nonse-
questered dsRNA. However, in the absence of interferon
treatment, the molar amounts of the K3L product were in
excess over the endogenous PKR levels, thereby allow-
ing K3L to function as a competitive inhibitor, thereby
preventing PKR activation (Fig. 9). These are the first
results to demonstrate K3L inhibiting PKR activation in an
in vivo viral system. When cells were pretreated with
interferon, the E3L products were still unable to mask the
dsRNA completely, and due to the interferon treatment,
PKR levels were now in excess over the K3L protein
thereby allowing PKR activation to occur (Fig. 9). Since
BHK cells did not appear to have a functional OAS
system, the excess dsRNA synthesized in the absence of
interferon did not lead to activation of this pathway.
Therefore, we propose that VVK3L cannot replicate in
untreated BHK cells since the high-level dsRNA formed
during virus replication cannot be fully sequestered by
E3L, leading to subsequent PKR binding and activation in
the absence of K3L. For VVE3L, the virus is not able to
FIG. 8. The level of unbound E3L protein was reduced in BHK cells as compared to HeLa cells. HeLa or BHK cells were untreated or pretreated
with IFN. The monolayers were then infected with wtVV. Cells were harvested at 6 and 12 h.p.i. and the total amount of E3L protein determined by
Western blot analysis. Extracts were also incubated with poly(rI)poly(rC)-agarose and the amount of E3L protein bound to the resin determined by
Western blot analysis. Given the high affinity of E3L for dsRNA, the amount of E3L bound to the resin represented the level of free E3L present in the
extract. By densitometric analysis, the percentage of free E3L was calculated and plotted.
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sequester the lower levels of dsRNA present in HeLa
cells allowing PKR binding, but since PKR levels are
much higher in HeLa cells, viral replication was blocked
irrespective of K3L synthesis. It should be noted that host
and viral translation is blocked in interferon-treated BHK
cells infected with VVE3L (Fig. 2B, lane F). However, in
cells infected with VVK3L a more specific block only in
viral protein synthesis was observed (Fig. 2B, lanes G
and H).
Since VV has a broad host range, these results sug-
gest an importance for the virus to maintain both a
functional E3L and a functional K3L gene in relationship
to this host range. Our results suggest that cell lines, and
likely different cell types in a mammal, differ in regards to
endogenous levels of PKR present and in the amount of
dsRNA made during a poxvirus infection. Late transcrip-
tion of VV genes leads to transcripts with extremely
heterogeneous 3 ends (Mahr and Roberts, 1984). Unfor-
tunately, relatively little is known about the mechanism of
termination of late transcription. VV transcription is reg-
ulated by a complex of proteins including the viral prod-
ucts of the H5R, G2R, and A18R genes and the viral RNA
polymerase (Black et al., 1998). Varying the levels of
these viral proteins or possibly unidentified host factors,
may alter the level of “promiscuous transcription,” result-
ing in the synthesis of longer-than-normal RNAs. These
effects could lead to varying concentrations of dsRNA in
different cell types.
These results suggest that VV may have evolved to
encode both the E3L gene and the K3L gene as a means
of expanding the viral host range. Depending on the cell
type infected, the necessity of either the E3L or the K3L
gene may vary. Cellular and viral factors likely will come
into play which will alter components of the cellular
antiviral response, such as PKR, or alter viral regulation




HeLa cells were maintained as monolayers in Dulbec-
co’s minimum essential media (DMEM) supplemented
with 50 g/ml gentamicin sulfate and 10% fetal bovine
serum (Hyclone). BHK cells were maintained in Eagle’s
minimum essential media (MEM) supplemented with
gentamicin and 10% fetal bovine serum. RK13 cells were
maintained in BHK media containing 5% fetal bovine
serum. Vaccinia virus VC-2 (Copenhagen strain), desig-
nated in this article as wtVV, was the parent strain for all
viruses used in this study. VV deleted for either E3L
(VVE3L or vP1080) or K3L (VVK3L or vP872) were
generated as previously described (Chang and Jacobs,
1993; Chang et al., 1995). For interferon treatment, cells
were treated with 100 IU/ml recombinant human  A/D
interferon (Hoffman-La Roche) for 18 h prior to infection.
Single-cycle virus growth
Indicated cell monolayers were infected at an m.o.i. 
1. At 1 h.p.i., the inoculum was removed, the monolayer
washed two times with PBS, and the media replaced.
Triplicate monolayers were infected to represent har-
vests at 0 h.p.i., and 30 h.p.i. with and without interferon
treatment. The 0 h.p.i. monolayers were harvested after
the 1 h infection process. Monolayers were harvested by
scraping the cells off the dish and into the media. Virus
was released from cells by three cycles of freeze/thaw-
FIG. 9.Model demonstrating the host-range dependence of VV replication on the presence of E3L or K3L. In HeLa cells, VV replication is dependent
on the presence of the E3L gene product to sequester the low levels of dsRNA synthesized during viral replication since the K3L gene product cannot
competitively inhibit the high levels of PKR present. In BHK cells, the E3L gene product cannot sequester the high levels of dsRNA synthesized, but
the K3L gene product, in the absence of interferon treatment, can competitively inhibit the lower levels of PKR present.
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ing. Virus titers were obtain by plaquing in RK13 cells
which has previously been shown to be permissive for all
viruses used in this study (Shors et al., 1997).
In vivo protein labeling
Cell monolayers, infected at an m.o.i.  5, were
starved for methionine at 5.5 h.p.i. using methionine-free
DMEM. At 6 h.p.i. newly synthesized proteins were la-
beled with 50 Ci of [35S]methionine per ml (800 Ci/
mmol) for 30 min. At that time, cytoplasmic extracts were
prepared by NP-40 detergent lysis (Chang and Jacobs,
1993)
RNA degradation assay
The amount of ribosomal RNA degradation was deter-
mined by isolating total RNA from infected cells at
12 h.p.i. Cells (4 106 cells) were scraped into the media
and washed one time in PBS. The cell pellet was resus-
pended in 1 ml of a 1:1 solution containing RNase-free
Tris-buffered saline (TBS) pH 7.0 and 25:24:1 phenol:
chloroform:isoamyl alcohol. The mixture was immedi-
ately vortexed for 1 min and centrifuged at 10,000 g for 5
min. An amount of 400 l of the aqueous phase was
transferred to a fresh tube and then 40 l of 3 M sodium
acetate pH 5.2 and 1 ml 100% ethanol were added. The
RNA was precipitated at 80°C for 30 min, followed by
centrifugation at 10,000 g for 30 min. The RNA pellets
were resuspended in 20 l 0.5% SDS and quantified. An
amount of 40 g ethidium bromide/ml was added to the
RNA (10 g) which was then separated on a 1.8% aga-
rose formaldehyde gel.
Level of eIF-2 phosphorylation
Indicated cell monolayers were infected at an m.o.i. 
5. At 6 h.p.i., RIPA cell lysates were prepared. Briefly,
cells were scraped into the media and pelleted at 500 g
for 5 min. The cell pellet was resuspended in RIPA lysis
buffer (1 PBS, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS, 50 mM NaF; 100 l per 4  106 cells) and
incubated on ice for 10 min. The lysate was centrifuged
at 10,000 g for 10 min and the supernatant transferred to
a new tube. An equal volume of 2 SDS-sample buffer
was added to the supernatant. The samples were boiled
and 30 l was analyzed on a 12% polyacrylamide mini-
gel. Separated proteins were transferred to nitrocellu-
lose using a CAPS transfer buffer (20 mM CAPS pH 11.0,
20% methanol). The nitrocellulose was blocked with
BLOTTO (20 mM Tris pH 7.5, 120 mM NaCl, 30% nonfat
dry milk). The blot was probed with rabbit anti-phospho-
rylated eIF2 (1:250 dilution; Research Genetics) for 18 h.
Secondary goat anti-rabbit IgG conjugated with horse-
radish peroxidase (1:5000) was added, followed by
chemiluminescent development and autoradiography. All
extracts were also probed by Western blot with goat
anti-eIF2 (Santa Cruz Biochemicals) to confirm equal
amounts of the protein (data not shown).
Levels of activated PKR
To determine the levels of activated PKR, Western blot
assays were performed. Two different antiserum were
used for these assays: monoclonal anti-PKR 71/10 (Ribo-
gene), which recognized human PKR (active and inactive
forms), and rabbit anti-PKR M-550 (Santa Cruz Biochemi-
cals; currently listed as M-115), which recognized non-
active forms of human and BHK cell PKR. Extracts were
prepared as described for determining “levels of eIF2
phosphorylation.” Proteins were separated on a large
format (12 cm) 7.5% polyacrylamide gel. Prestained stan-
dards were loaded on the gel and the proteins separated
until the 50-kDa prestained standard migrated to the
bottom of the gel. Western blot analysis was performed
as described above using the manufacturer’s recom-
mended antiserum dilution.
To dephosphorylate activated PKR in the samples,
extracts were prepared as described above; only the
RIPA lysis buffer did not contain NaF. Cellular extracts
were diluted fourfold (in 20 mm HEPES pH 7.5, 10%
glycerol) followed by the addition of 400 U calf intestinal
alkaline phosphatase/ml (Boehringer Mannheim) and in-
cubation for 5 min at 37°C (Langland and Jacobs, 1992).
Levels of E3L protein
To determine the levels of E3L protein, Western blot
analysis was performed as described above using a 12%
polyacrylamide minigel and rabbit anti-E3L antiserum
(1:500). To determine the levels of E3L not bound to
dsRNA (free E3L), NP-40 detergent lysates were pre-
pared. A portion of the extract was incubated with
poly(rI)poly(rC) agarose (Langland et al., 1995) and the
amount of E3L protein bound to the resin determined by
Western blot analysis (free E3L). The amount of total E3L
protein present in the extract was also determined by
Western blot analysis. By densitometric analysis, the
percentage of free E3L was then calculated.
Levels of dsRNA
A modified procedure as described by Bayliss and
Condit (1993) was used to measure the amount of hy-
bridized RNA (dsRNA) present in an infected cell. Briefly,
100-mm confluent monolayers of cells were infected at
an m.o.i. 10. Two hours prior to harvest, the media was
removed and replaced with 1 ml DMEM containing 1 mCi
[3H]uridine. The media was rocked over the cells every
15 min to prevent drying. At the indicated harvest times,
cells were scraped into the media and washed two times
in cold PBS. The cells were lysed and the RNA purified
using the SNAP RNA isolation kit (Invitrogen). The RNA
was resuspended in 10 mM Tris pH 7.6 (125 l) and 1/50
of this isolated RNA was spotted directly onto a glass
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fiber filter, washed two times in cold 10% TCA and one
time in 95% ethanol, and the amount of radioactivity
determined by scintillation counting (total RNA). The re-
maining purified RNA sample was divided equally. One
aliquot (50 l) was heated to 100°C for 2 min and al-
lowed to slow cool to room temperature. The sample
was overlaid with 100 l mineral oil and incubated for
20 h at 68°C. An amount of 20 g tRNA was added to
both of the RNA samples (boiled/hybridized and non-
boiled/nonhybridized). The samples were then brought
to 0.4 M NaCl and 0.03 M sodium citrate along with the
addition of 50 g RNase A and 2.5 g RNase T1. The
samples were incubated at 37°C for 1 h; an additional 10
g tRNA was added and the samples spotted on glass
fiber filters. The RNA was precipitated and washed two
times in cold 10% TCA containing 0.01 M sodium pyro-
phosphate and one time in 95% ethanol, and the amount
of radioactivity determined by scintillation counting. The
percentage RNase-resistant RNA (dsRNA) was then cal-
culated by comparison to the total amount of RNA.
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